EUVIMEDEUVIMED entdecken
Crossref

Epsolay - A Benzoyl Peroxide Cream for Rosacea

The Medical Letter on Drugs and Therapeutics · 2023

DOI: 10.58347/tml.2023.1669c ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, 2023. Hauptthemen laut MEDLINE: Rosacea, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epsolay (Galderma), a 5% benzoyl peroxide cream, has been approved by the FDA for treatment of inflammatory lesions of rosacea in adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosaceaDermatologic AgentsHumansBenzoyl PeroxideMetronidazoleAdministration, Cutaneous

Stichwörter der Autor:innen

EpsolayMetrogeladverse effectsazelaic acidbenzoyl peroxidedosagedoxycyclineefficacyivermectinlactationmetronidazoleminocyclinepregnancyrosaceasafety

Substanzen

Benzoyl PeroxideMetronidazoleDermatologic Agents

Zitieren

APA

(2023). Epsolay - A Benzoyl Peroxide Cream for Rosacea. The Medical Letter on Drugs and Therapeutics. https://doi.org/10.58347/tml.2023.1669c

Vancouver

Epsolay - A Benzoyl Peroxide Cream for Rosacea. The Medical Letter on Drugs and Therapeutics. 2023. doi:10.58347/tml.2023.1669c

BibTeX
@article{euvimed2023,
  title = {Epsolay - A Benzoyl Peroxide Cream for Rosacea},
  journal = {The Medical Letter on Drugs and Therapeutics},
  year = {2023},
  doi = {10.58347/tml.2023.1669c}
}
Kostenlos starten →